Analysis of the Degree Distribution of HIV Transmission Networks Inferred from Viral Sequence Data. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
Antiretroviral drug resistance in pregnant women living with HIV in England and Wales: Preliminary results from the matching of three national HIV surveillance databases. British HIV Association Conference (BHIVA) 2015.. 2015.
Automated Analysis of A1 cluster dynamics in the UK 2007-2010. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.. 2012.
Bayesian models in the analysis of HIV drug resistance data from the UK HIV Drug Resistance Database. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.. 2006.
Bayesian Phylogeography of HIV among MSM in the UK Indicates a Few Source Areas of Widespread Infection. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
The biology, epidemiology and clinical implications of transmitted HIV drug resistant viruses. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.. 2009.
Characterising HIV transmission risk factors using genetic source attribution and phylogenetic clustering. HIV Dynamics and Evolution Meeting 2016.. 2016.
Clustering and Geography: analysis of HIV transmission among UK MSM. 16th International HIV Dynamics & Evolution Meeting, April 2009.. 2009.
Combining ambiguous nucleotide calls with longitudinal CD4 counts and viral load measurements to derive patient-specific distributions for date of HIV seroconversion. 21st International Workshop on HIV and Hepatitis Observational Databases.. 2017.
The contribution of recent infections to HIV-1 transmission clusters in the UK. 18th International HIV Dynamics and Evolution Conference, 1-4 May 2011.. 2011.
Demonstration of sustained drug-resistant HIV-1 lineages circulating among treatment-naïve individuals. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.. 2009.
Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viraemia. 18th International HIV Drug Resistance Workshop, June 2009.. 2009.
Detection of NNRTI resistance mutations after interrupting NNRTI-based regimens. Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014.. 2014.
Different drug-resistance development in HIV-1 infected patients failing a first-line antiretroviral therapy containing NNRTIs. IAS, 17-20 July 2011.. 2011.
Dynamics of Non-B HIV Transmission in the UK. 20th Conference on Retroviruses and Opportunistic Infections, 3-6 March 2013.. 2013.
Effect of HIV-1 subtype on virological and immunological response to first-line HAART. 6th European HIV Drug Resistance Workshop, 26-28 March 2008.. 2008.
Effect of HIV-1 subtype on virological and immunological response to first-line HAART. British HIV Association 14th Annual Conference, 23-25 April 2008.. 2008.
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.. 2010.
The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort. 18th Annual Conference of the British HIV Association, 18-20 April 2012.. 2012.